#Vikings #Defense #NFL #SKOL
#Vikings #Defense #NFL #SKOL
I read the current issue with interest and then saw that this was the last issue, another victim of the new HHS.
I read the current issue with interest and then saw that this was the last issue, another victim of the new HHS.
I’m so proud of this amazing young woman! ❤️
Thanks to all of her faculty and friends and family who supported her during her college years. 🙏🏽
I’m so proud of this amazing young woman! ❤️
Thanks to all of her faculty and friends and family who supported her during her college years. 🙏🏽
Such a privilege to represent @ucsfcancer.bsky.social and @astct.bsky.social to work with other key leaders to advance development and access of transformational therapies.
Such a privilege to represent @ucsfcancer.bsky.social and @astct.bsky.social to work with other key leaders to advance development and access of transformational therapies.
Amazing to see even more improvement with bispecific antibody #immunotherapy presented in the #ASH24 Plenary session. #hematology #leukemia
Amazing to see even more improvement with bispecific antibody #immunotherapy presented in the #ASH24 Plenary session. #hematology #leukemia
Overall, higher ICANS rate and much longer LOS (30d vs. 16d) v. age 65-79. Long LOS driven by toxicity.
Similar overall PFS, outcomes suggest safety/efficacy in selected patients. #ASH24 #immunotherapy
Overall, higher ICANS rate and much longer LOS (30d vs. 16d) v. age 65-79. Long LOS driven by toxicity.
Similar overall PFS, outcomes suggest safety/efficacy in selected patients. #ASH24 #immunotherapy
Another reason to #EndMOC by the ABIM.
Another reason to #EndMOC by the ABIM.